The immune regulatory capacity of released galanin and its receptors was proven in various animal models of inflammatory diseases, including inflammatory bowel disease (IBD), arthritis, dermatitis, psoriasis and pancreatitis28–34. The gene discussed is GAL; the disease is skin disorder.